Organisation paid for research Program year 2025 Source: CMS Open Payments

Jacksonville Center for Clinical

Neither a doctor nor a teaching hospital

Research payments

$847,680

333 payments

Through program year 2025, Jacksonville Center for Clinical is reported as receiving $847,680 in research payments, across 333 payments.

By program year

7 rows
Year Kind Amount Payments
2025 Research $20,478 23
2024 Research $67,977 15
2023 Research $34,772 14
2022 Research $328,362 144
2021 Research $293,634 95
2020 Research $50,533 41
2019 Research $51,923 1

Breakdown

Who paid Research payments · program years 2019–2025
  1. GlaxoSmithKline, LLC. $613,028 193 payments
  2. Boston Scientific Corporation $127,540 59 payments
  3. Otsuka Pharmaceutical Development & Commercialization, Inc. $51,923 1 payment
  4. Esperion Therapeutics, Inc. $31,666 75 payments
  5. Boehringer Ingelheim Pharmaceuticals, Inc. $11,750 1 payment
  6. F. Hoffmann-La Roche AG $10,500 1 payment
  7. Mitsubishi Tanabe Pharma Development America, Inc. $953 1 payment
  8. Moderna TX, Inc. $167 1 payment
  9. Amgen Inc. $152 1 payment
Studies the money was for Research payments · program years 2019–2025
  1. A Phase 3, Randomized, Placebo-Controlled, Observer-Blind, Multi-Count $313,383 135 payments
  2. Study name not reported $259,656 40 payments
  3. Lux-Dx Trends $88,455 38 payments
  4. A Phase 3B, Multi-Center, Open-Label Trial to Evaluate the Long Term Safety of Titrated Immediate-Release Tolvaptan Opc-41061, 30 MG to 120 Mgday, Split Dose in Subjects With Autosomal Dominant Polycystic Kidney Disease $51,923 1 payment
  5. A Phase I/II, Randomized, Placebo-Controlled, Observer-Blind, Multicen $35,681 16 payments
  6. Lux DX Trends $34,606 13 payments
  7. A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Effects of Bempedoic Acid (Etc-1002) on the Occurrence of Major Cardiovascular Events in Patients With, Or at High Risk For, Cardiovascular Disease Who Are Statin Intolerant $31,666 75 payments
  8. Safety & Efficacy of Empa in patients with Acute H $11,750 1 payment
  9. Igg Il2 Ph1b in UC $10,500 1 payment
  10. Lux Trends $4,479 8 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record